Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 42,337 | reported | 08 Feb 2023 | tx 107+660,803−341,263 |
| CADENCE PHARMACEUTICALS INC | 0 | reported | 19 Mar 2014 | tx 19+204,000−788,170 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2023 | SALE | NEUROCRINE BIOSCIENCES INC | 801 | 105.82 USD | |
| 08 Feb 2023 | SALE | NEUROCRINE BIOSCIENCES INC | 701 | 103.83 USD | |
| 07 Feb 2023 | SALE | NEUROCRINE BIOSCIENCES INC | 12,801 | 102.41 USD | |
| 07 Feb 2023 | SALE | NEUROCRINE BIOSCIENCES INC | 1,015 | 102.16 USD | |
| 31 Jan 2023 | SALE | NEUROCRINE BIOSCIENCES INC | 1,666 | 110.02 USD | |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,361 | 43.24 USD | |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,455 | 35.99 USD | |
| 12 Aug 2022 | SALE | NEUROCRINE BIOSCIENCES INC | 21,533 | 105.95 USD | |
| 12 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 21,533 | 35.99 USD | |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,227 | 81.49 USD | |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,227 | 81.49 USD | deriv |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,361 | 43.24 USD | deriv |
| 12 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 21,533 | 35.99 USD | deriv |
| 15 Aug 2022 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,455 | 35.99 USD | deriv |
| 07 Feb 2022 | SALE | NEUROCRINE BIOSCIENCES INC | 801 | 80.65 USD | |
| 07 Feb 2022 | SALE | NEUROCRINE BIOSCIENCES INC | 1,015 | 80.73 USD | |
| 07 Feb 2022 | SALE | NEUROCRINE BIOSCIENCES INC | 865 | 80.78 USD | |
| 08 Feb 2022 | SALE | NEUROCRINE BIOSCIENCES INC | 701 | 79.53 USD | |
| 31 Jan 2022 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 21,546 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,164 | 0.00 USD | deriv |
| 27 Jul 2021 | SALE | NEUROCRINE BIOSCIENCES INC | 16,709 | 93.80 USD | |
| 10 Feb 2021 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,100 | 35.99 USD | |
| 10 Feb 2021 | SALE | NEUROCRINE BIOSCIENCES INC | 600 | 119.95 USD | |
| 10 Feb 2021 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 600 | 35.99 USD | |
| 10 Feb 2021 | SALE | NEUROCRINE BIOSCIENCES INC | 1,100 | 119.96 USD |